Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,000 shares at $33.60 ($331K) on 2014-11-12, disclosed to the SEC on 2014-11-14.
Scheduled sale ($331k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.45 | 2,036 | $66K | 19.9% |
| 2 | $32.48 | 2,065 | $67K | 20.2% |
| 3 | $33.60 | 2,964 | $100K | 30.1% |
| 4 | $33.62 | 2,935 | $99K | 29.8% |
| Total | $33.14 avg | 10,000 | $331K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |